| 0.8 |
2.5 |
GO:0046449 |
allantoin metabolic process(GO:0000255) mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
| 0.8 |
4.6 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.5 |
1.4 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.3 |
1.3 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.3 |
2.5 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.3 |
0.8 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.3 |
0.8 |
GO:0071848 |
regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) TNFSF11-mediated signaling pathway(GO:0071847) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.2 |
1.6 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.2 |
0.8 |
GO:0006922 |
obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
| 0.2 |
0.6 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.2 |
2.1 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.2 |
0.6 |
GO:0001300 |
chronological cell aging(GO:0001300) detection of hypoxia(GO:0070483) |
| 0.2 |
0.7 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.2 |
0.6 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
2.5 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.2 |
2.0 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 |
1.0 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.1 |
0.7 |
GO:0030578 |
nuclear body organization(GO:0030575) PML body organization(GO:0030578) |
| 0.1 |
2.0 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.9 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
0.1 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.1 |
0.7 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.1 |
0.6 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.9 |
GO:0006893 |
Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
| 0.1 |
5.3 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.1 |
1.1 |
GO:0006835 |
dicarboxylic acid transport(GO:0006835) |
| 0.1 |
0.9 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.1 |
1.1 |
GO:1901798 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.1 |
0.3 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
0.8 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.1 |
0.5 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.1 |
0.7 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.1 |
2.0 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 0.1 |
0.4 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.1 |
0.4 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 |
0.6 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.1 |
7.3 |
GO:0007605 |
sensory perception of sound(GO:0007605) |
| 0.1 |
0.6 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.1 |
0.4 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
| 0.1 |
0.3 |
GO:0002689 |
negative regulation of leukocyte chemotaxis(GO:0002689) |
| 0.1 |
0.7 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.1 |
1.0 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.1 |
0.3 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 |
0.9 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 |
1.6 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
0.2 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.1 |
0.7 |
GO:0051319 |
mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
| 0.1 |
0.2 |
GO:0071025 |
RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 |
0.2 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.1 |
0.2 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.1 |
0.2 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
0.3 |
GO:0032656 |
regulation of interleukin-13 production(GO:0032656) |
| 0.1 |
0.3 |
GO:0042637 |
catagen(GO:0042637) |
| 0.1 |
0.3 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 |
0.3 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.1 |
0.3 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.0 |
1.2 |
GO:0002504 |
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.0 |
0.3 |
GO:0000281 |
mitotic cytokinesis(GO:0000281) |
| 0.0 |
0.9 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.4 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.0 |
1.7 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.0 |
4.6 |
GO:0010827 |
regulation of glucose transport(GO:0010827) |
| 0.0 |
1.5 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.6 |
GO:0033523 |
histone monoubiquitination(GO:0010390) histone H2B ubiquitination(GO:0033523) |
| 0.0 |
0.2 |
GO:0060346 |
midbrain-hindbrain boundary development(GO:0030917) bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
| 0.0 |
1.0 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.0 |
0.6 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.0 |
0.2 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.0 |
1.0 |
GO:0030010 |
establishment of cell polarity(GO:0030010) |
| 0.0 |
1.4 |
GO:0050931 |
melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
| 0.0 |
2.4 |
GO:0061025 |
membrane fusion(GO:0061025) |
| 0.0 |
0.3 |
GO:0014037 |
Schwann cell differentiation(GO:0014037) |
| 0.0 |
0.7 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
| 0.0 |
0.2 |
GO:0060123 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) regulation of growth hormone secretion(GO:0060123) positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 |
3.1 |
GO:0006865 |
amino acid transport(GO:0006865) |
| 0.0 |
0.4 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.0 |
0.4 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.0 |
0.7 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.5 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 |
1.0 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.4 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 |
0.6 |
GO:0070830 |
bicellular tight junction assembly(GO:0070830) |
| 0.0 |
0.1 |
GO:0045872 |
regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 |
0.4 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.0 |
0.4 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
0.1 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.1 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
| 0.0 |
0.1 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 |
0.3 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.0 |
0.3 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 |
0.3 |
GO:0001974 |
blood vessel remodeling(GO:0001974) |
| 0.0 |
1.8 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.9 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.1 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) proline catabolic process(GO:0006562) |
| 0.0 |
1.0 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.0 |
2.0 |
GO:0030900 |
forebrain development(GO:0030900) |
| 0.0 |
1.1 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.2 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.0 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) diaphragm development(GO:0060539) |
| 0.0 |
0.2 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.0 |
0.0 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
| 0.0 |
0.4 |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway(GO:0090090) |
